IL-10 AND IL-35 AS INFLAMMATION REGULATORS IN PATIENTS WITH ALLERGIC RHINITIS AND MILD ATOPIC ASTHMA
Article Sidebar
Main Article Content
Abstract
Background. Significantly less is known about the immunoregulative cytokines, especially in allergic airway disease. This study aims to present the involvement of IL-35 and IL-10 in patients with allergic rhinitis (AR) and allergic bronchial asthma (BA). Methodology. The study comprised 71 patients –AR, patients with concomitant AR and mild atopic BA, and healthy controls (HC). We examined the serum levels of IL-35 and IL-10, along with other instrumental examinations, between March and September 2021. Findings. Levels of the regulatory cytokines IL-35 and IL-10 were significantly lower in patients than in HC (87.19±11.90 vs. 96.12±1.79 pg/ml; and 30.26±17.55 vs. 111.56±65.03 pg/ml, respectively). Furthermore, threefold higher serum IL-10 levels were found in healthy subjects compared to patients (p = 0.006). No difference in the levels of interleukins was found between the studied groups. Conclusions. Our results indicate that elevated IL-35 and IL-10 may play an essential role in reducing the activity of underlying allergic inflammation in allergic respiratory diseases, although no difference in the levels of the studied cytokines was found between the different groups of patients. Therefore, we can speculate that the immunosuppressive cytokines IL-35 and IL-10 were involved in maintaining the healthy state of no inflammation.
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Akdis, M., Verhagen, J., Taylor, A., Karamloo, F., Karagiannidis, C., Crameri, R., Thunberg, S., Deniz, G., Valenta, R., Fiebig, H., Kegel, C., Disch, R., Schmidt-Weber, C. B., Blaser, K., & Akdis, C. A. (2004). Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. The Journal of experimental medicine, 199(11), 1567–1575. https://doi.org/10.1084/jem.20032058
Barnes P. J. (2008). The cytokine network in asthma and chronic obstructive pulmonary disease. The Journal of clinical investigation, 118(11), 3546–3556. https://doi.org/10.1172/JCI36130
Bayrak Degirmenci, P., Aksun, S., Altin, Z., Bilgir, F., Arslan, I. B., Colak, H., Ural, B., Solakoglu Kahraman, D., Diniz, G., Ozdemir, B., & Kırmaz, C. (2018). Allergic Rhinitis and Its Relationship with IL-10, IL-17, TGF-β, IFN-γ, IL 22, and IL-35. Disease markers, 2018, 9131432. https://doi.org/10.1155/2018/9131432
Bousquet, J., Van Cauwenberge, P., Khaltaev, N., Aria Workshop Group, & World Health Organization (2001). Allergic rhinitis and its impact on asthma. The Journal of allergy and clinical immunology, 108(5 Suppl), S147–S334. https://doi.org/10.1067/mai.2001.118891
Chen C., Deng Y., Chen H., Wu X., Cheng S., Xu Y., Xiong W., Xie J.(2014). Decreased concentration of IL-35 in plasma of patients with asthma and COPD. Asian Pac. J. Allergy Immunol. 32, 211–217. https://doi.org/10.12932/AP0403.32.3.2014
Ciprandi, G., Cirillo, I., Vizzaccaro, A., Tosca, M., Passalacqua, G., Pallestrini, E., & Canonica, G. W. (2005). Seasonal and perennial allergic rhinitis: is this classification adherent to real life?. Allergy, 60(7), 882–887. https://doi.org/10.1111/j.1398-9995.2005.00602.x
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. (2007). The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature, 450(7169), 566–569. https://doi.org/10.1038/nature06306
Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R., & Romagnani, S. (1993). Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. Journal of immunology (Baltimore, Md. : 1950), 150(2), 353–360.
Dong, J., Wong, C. K., Cai, Z., Jiao, D., Chu, M., & Lam, C. W. (2015). Amelioration of allergic airway inflammation in mice by regulatory IL-35 through dampening inflammatory dendritic cells. Allergy, 70(8), 921–932. https://doi.org/10.1111/all.12631
Dons, E. M., Raimondi, G., Cooper, D. K., & Thomson, A. W. (2012). Induced regulatory T cells: mechanisms of conversion and suppressive potential. Human immunology, 73(4), 328–334. https://doi.org/10.1016/j.humimm.2011.12.011
Global Initiative for Asthma. GINA Report, global strategy for asthma management and prevention. Retrieved from http://www.ginasthma.org
Hawrylowicz C. M. (2005). Regulatory T cells and IL-10 in allergic inflammation. The Journal of experimental medicine, 202(11), 1459–1463.
Hawrylowicz, C. M., & O'Garra, A. (2005). Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nature reviews. Immunology, 5(4), 271–283. https://doi.org/10.1038/nri1589
Huang, C. H., Loo, E. X., Kuo, I. C., Soh, G. H., Goh, D. L., Lee, B. W., & Chua, K. Y. (2011). Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. Journal of immunology (Baltimore, Md.: 1950), 187(1), 462–471. https://doi.org/10.4049/jimmunol.1100259
Kanai, K., Park, A. M., Yoshida, H., Tsunoda, I., & Yoshie, O. (2017). IL-35 Suppresses Lipopolysaccharide-Induced Airway Eosinophilia in EBI3-Deficient Mice. Journal of immunology (Baltimore, Md.: 1950), 198(1), 119–127. https://doi.org/10.4049/jimmunol.1600506
Kouzaki, H., Arai, Y., Nakamura, K., Murao, T., Tojima, I., Shimizu, S., Yuta, A., & Shimizu, T. (2021). Anti-inflammatory roles of interleukin-35 in the pathogenesis of Japanese cedar pollinosis. Asia Pacific allergy, 11(3), e34. https://doi.org/10.5415/apallergy.2021.11.e34
Lipworth, B. J., & Clark, D. J. (1997). Effects of airway calibre on lung delivery of nebulised salbutamol. Thorax, 52(12), 1036–1039. https://doi.org/10.1136/thx.52.12.1036
Liu, W., Zeng, Q., Wen, Y., Tang, Y., Yan, S., Li, Y., Zhou, L., & Luo, R. (2021). Inhibited interleukin 35 expression and interleukin 35-induced regulatory T cells promote type II innate lymphoid cell response in allergic rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 126(2), 152–161.e1.https://doi.org/10.1016/j.anai.2020.08.005
Lloyd, C. M., & Hawrylowicz, C. M. (2009). Regulatory T cells in asthma. Immunity, 31(3), 438–449. https://doi.org/10.1016/j.immuni.2009.08.007
Naydenova, K.; Dimitrov, V.; Velikova, T. (2021).Immunological and microRNA Features of Allergic Rhinitis in the Context of United Airway Disease. Sinusitis, 5, 45-52. https://doi.org/10.3390/sinusitis5010005
Pillai, M. R., Collison, L. W., Wang, X., Finkelstein, D., Rehg, J. E., Boyd, K., Szymczak-Workman, A. L., Doggett, T., Griffith, T. S., Ferguson, T. A., & Vignali, D. A. (2011). The plasticity of regulatory T cell function. Journal of immunology (Baltimore, Md. : 1950), 187(10), 4987–4997. https://doi.org/10.4049/jimmunol.1102173
Romagnani S. (2000). T-cell subsets (Th1 versus Th2). Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 85(1), 9–21. https://doi.org/10.1016/S1081-1206(10)62426-
Sawant, D.V., Hamilton, K., & Vignali, D. A. (2015). Interleukin-35: Expanding Its Job Profile. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 35(7), 499–512. https://doi.org/10.1089/jir.2015.0015
Shamji, M. H., & Durham, S. R. (2017). Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. The Journal of allergy and clinical immunology, 140(6), 1485–1498. https://doi.org/10.1016/j.jaci.2017.10.010
Suzuki, M., Yokota, M., Nakamura, Y., Ozaki, S., & Murakami, S. (2017). Intranasal administration of IL-35 inhibits allergic responses and symptoms in mice with allergic rhinitis. Allergology international: official journal of the Japanese Society of Allergology, 66(2), 351–356. https://doi.org/10.1016/j.alit.2016.08.014
Vignali, D. A., Collison, L. W., & Workman, C. J. (2008). How regulatory T cells work. Nature reviews. Immunology, 8(7), 523–532. https://doi.org/10.1038/nri2343
Wang, W., Li, P., Chen, Y. F., & Yang, J. (2015). A potential immunopathogenic role for reduced IL-35 expression in allergic asthma. The Journal of asthma : official journal of the Association for the Care of Asthma, 52(8), 763–771. https://doi.org/10.3109/02770903.2015.1038390
Wang, W., Wei, C., Cheng, Z., & Yang, J. (2020). Aberrant Th2 Immune Responses Are Associated With a Reduced Frequency of IL-35-Induced Regulatory T Cells After Allergen Exposure in Patients With Allergic Asthma. Allergy, asthma & immunology research, 12(6), 1029–1045. https://doi.org/10.4168/aair.2020.12.6.1029
Yokota, M., Suzuki, M., Nakamura, Y., Ozaki, S., & Murakami, S. (2015). Cytokine modulation by IL-35 in mice with allergic rhinitis. American journal of rhinology & allergy, 29(4), 251–256. https://doi.org/10.2500/ajra.2015.29.4188